Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug 29;403(11-12):985-1003.
doi: 10.1515/hsz-2022-0205. Print 2022 Nov 25.

A primer on heme biosynthesis

Affiliations
Review

A primer on heme biosynthesis

Harry A Dailey et al. Biol Chem. .

Abstract

Heme (protoheme IX) is an essential cofactor for a large variety of proteins whose functions vary from one electron reactions to binding gases. While not ubiquitous, heme is found in the great majority of known life forms. Unlike most cofactors that are acquired from dietary sources, the vast majority of organisms that utilize heme possess a complete pathway to synthesize the compound. Indeed, dietary heme is most frequently utilized as an iron source and not as a source of heme. In Nature there are now known to exist three pathways to synthesize heme. These are the siroheme dependent (SHD) pathway which is the most ancient, but least common of the three; the coproporphyrin dependent (CPD) pathway which with one known exception is found only in gram positive bacteria; and the protoporphyrin dependent (PPD) pathway which is found in gram negative bacteria and all eukaryotes. All three pathways share a core set of enzymes to convert the first committed intermediate, 5-aminolevulinate (ALA) into uroporphyrinogen III. In the current review all three pathways are reviewed as well as the two known pathways to synthesize ALA. In addition, interesting features of some heme biosynthesis enzymes are discussed as are the regulation and disorders of heme biosynthesis.

Keywords: coproporphyrin dependent pathway; heme; mitochondrial heme metabolon; porphyria; protoporphyrin dependent pathway; siroheme dependent pathway.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Agostinis, P., Berg, K., Cengel, K.A., Foster, T.H., Girotti, A.W., Gollnick, S.O., Hahn, S.M., Hamblin, M.R., Juzeniene, A., Kessel, D., et al.. (2011). Photodynamic therapy of cancer: an update. Ca – Cancer J. Clin. 61: 250–281, https://doi.org/10.3322/caac.20114.
    1. Al-Karadaghi, S., Hansson, M., Nikonov, S., Jonsson, B., and Hederstedt, L. (1997). Crystal structure of ferrochelatase: the terminal enzyme in heme biosynthesis. Structure 5: 1501–1510, https://doi.org/10.1016/s0969-2126(97)00299-2.
    1. Astner, I., Schulze, J.O., van den Heuvel, J., Jahn, D., Schubert, W.D., and Heinz, D.W. (2005). Crystal structure of 5-aminolevulinate synthase, the first enzyme of heme biosynthesis, and its link to XLSA in humans. EMBO J. 24: 3166–3177, https://doi.org/10.1038/sj.emboj.7600792.
    1. Bai, Y., Kim, J.Y., Bisunke, B., Jayne, L.A., Silvaroli, J.A., Balzer, M.S., Gandhi, M., Huang, K.M., Sander, V., Prosek, J., et al.. (2021). Kidney toxicity of the BRAF-kinase inhibitor vemurafenib is driven by off-target ferrochelatase inhibition. Kidney Int. 100: 1214–1226, https://doi.org/10.1016/j.kint.2021.08.022.
    1. Bailey, H.J., Bezerra, G.A., Marcero, J.R., Padhi, S., Foster, W.R., Rembeza, E., Roy, A., Bishop, D.F., Desnick, R.J., Bulusu, G., et al.. (2020). Human aminolevulinate synthase structure reveals a eukaryotic-specific autoinhibitory loop regulating substrate binding and product release. Nat. Commun. 11: 2813, https://doi.org/10.1038/s41467-020-16586-x.

Publication types

LinkOut - more resources